1620 Investment Advisors »

Adial Pharmaceuticals shares owned by 1620 Investment Advisors

Quarter-by-quarter ownership of Adial Pharmaceuticals (ADIL) shares owned by 1620 Investment Advisors from 13F filings

Historical chart of 1620 Investment Advisors investment in Adial Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Adial Pharmaceuticals held by 1620 Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adial Pharmaceuticals by 1620 Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.6k 3.6k 1.00
2024-06-30 $4.1k 3.6k 1.15

More positions owned by 1620 Investment Advisors

SPDR Portfolio Intrmdt Term Corp Bd ETF Etf (SPIB)
iShares 7-10 Year Treasury Bond ETF Etf (IEF)
SPDR MSCI EAFE StrategicFactors ETF Etf (QEFA)
SPDR S&P 600 Small Cap ETF Etf
Tri Continental Corporation Etf (TY)
SPDR Ptf Short-Term Treasury ETF Etf (SPTS)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
TJX Companies (TJX)
iShares Short Term Ntnl Muni Bond ETF Etf (SUB)
iShares Short-Term Corporate Bond ETF Etf (IGSB)
Microsoft Corporation (MSFT)
Freedom 100 Emerging Markets ETF Etf (FRDM)
Schwab U.S. TIPS ETF Etf (SCHP)
SPDR Doubleline Total Return Tactical ETF Etf (TOTL)

View all positions for 1620 Investment Advisors

Top funds holding Adial Pharmaceuticals

Manchester Capital Management
Geode Capital Management
Citadel Advisors
BlackRock
BlackRock
Tower Research Capital
1620 Investment Advisors
Bank of America Corporation
Benjamin F. Edwards & Company
Morgan Stanley
Abound Wealth Management
Qube Research & Technologies

View all funds holding Adial Pharmaceuticals